Send Inquiry

Request To Call Back

4 Mg Zoledronic Acid Injection IP

Name: 4 Mg Zoledronic Acid Injection IP
Brand: NEETCO BIOPHARMA
Price: 499 INR
Availability: InStock

Price 499 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

4 Mg Zoledronic Acid Injection IP Specification

Indication
Treatment of osteoporosis, Pagets disease, hypercalcemia of malignancy, bone metastases

Dosage Form
Injection (Lyophilized Powder for Solution)

Salt Composition
Zoledronic Acid 4 mg

Feature
Single-dose vial, potent bisphosphonate for bone disorders

Ingredients
Zoledronic Acid, Mannitol, Sodium Citrate

Application
Intravenous administration

Ph Level
Adjusted to appropriate pharmaceutical standards (usually around 4.5-5.5 for infusion)

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light, do not freeze

Shelf Life
24 months from manufacturing date

Warnings and Precautions
Monitor renal function, hydrate patient adequately before administration

Infusion Duration
Administer slowly over no less than 15 minutes

Route of Administration
Intravenous infusion

Dilution Recommendation
Further diluted in 100 ml of 0.9% sodium chloride or 5% dextrose solution

Batch Number & Expiry
Printed on vial label

Pack Size
Single vial containing 4 mg zoledronic acid

Prescription Status
Prescription only

Barcode
Present on packaging

Reconstitution Instructions
Dissolve with 5 ml sterile water for injection as per label directions

Registration Number
As per country-specific drug regulatory authority

Side Effects
Possible flu-like symptoms, bone/joint pain, nausea, headache

Contraindications
Pregnancy, lactation, severe renal impairment

Compliance Standards
IP (Indian Pharmacopoeia)

About 4 Mg Zoledronic Acid Injection IP

Experience the ultimate care in bone health with our 4 Mg Zoledronic Acid Injection IP. Crafted as a radiant, potent bisphosphonate, this affordable solution comes in a single-dose vial with instant checkout available for seamless procurement. Featuring 4 mg zoledronic acid as a commanding ingredient, the lyophilized powder is odorless with a white to off-white hue. Designed for intravenous infusion, it treats osteoporosis, Paget's disease, bone metastases, and hypercalcemia of malignancy. Each batch complies with rigorous IP standards, ensuring high safety, efficacy, and traceability. Hydration and renal function monitoring are advised.

How to Use and Key Features of 4 Mg Zoledronic Acid Injection IP

For optimal effectiveness, reconstitute the single-dose vial with 5 ml sterile water, as directed. Administer intravenously after further dilution in 100 ml of 0.9% sodium chloride or 5% dextrose, strictly over a minimum of 15 minutes. This commanding medication addresses osteoporosis, Paget's disease, bone metastases, and hypercalcemia related to malignancy. Odorless and featuring a white to off-white lyophilized powder, the injection assures pharmaceutical-grade precision and robust stabilization for single-use application.

Supply, Outlay, Payment & Certifications for Global Dispatch

With a reliable dispatching process, our capability as a prominent distributor, exporter, supplier, and trader ensures prompt delivery of 4 Mg Zoledronic Acid Injection IP across India and global destinations. Outlay terms are competitive, supporting a wide spectrum of payment options for ease of transaction. Every batch is dispatched under strict regulatory approvals, upholding IP certification, and includes batch and expiry information on the label for complete traceability throughout the supply chain.

FAQ's of 4 Mg Zoledronic Acid Injection IP:

Q: How is the 4 Mg Zoledronic Acid Injection IP administered?

A: The injection is prepared by dissolving the lyophilized powder in 5 ml sterile water, then further diluted in 100 ml of 0.9% sodium chloride or 5% dextrose and administered intravenously over at least 15 minutes.

Q: What conditions does this injection specifically treat?

A: It is indicated for osteoporosis, Paget's disease of bone, bone metastases, and hypercalcemia of malignancy, offering potent support in bone health management.

Q: When should hydration and renal monitoring be performed?

A: Patients should be adequately hydrated before administration, and renal function should be monitored both prior to and after the infusion, especially in those with pre-existing renal impairment.

Q: Where can I verify batch number, barcode, and expiry details?

A: All critical information, including batch number, expiry date, and a scannable barcode, is printed on the vial label and packaging for transparency and compliance.

Q: What are the main precautions and possible side effects?

A: Contraindicated during pregnancy, lactation, and severe renal issues, the injection may cause flu-like symptoms, bone or joint pain, nausea, or headache. Always administer under medical supervision.

Q: What compliance standards and certifications does this product meet?

A: Each vial complies with Indian Pharmacopoeia (IP) standards, and is dispatched with necessary regulatory authorizations as per country-specific requirements, ensuring safety and quality.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Anti Cancer Injection Category

30 Mg Octreotide Injection

Price 14499 INR / Vial

Minimum Order Quantity : 1 Vial

Indication : Used to treat acromegaly, severe diarrhea and flushing episodes associated with metastatic carcinoid tumors, and vasoactive intestinal peptide tumors (VIPomas).

Storage Instructions : Store in refrigerator at 2C to 8C (36F to 46F); do not freeze. Protect from light.

Shelf Life : 24 months from manufacturing date

Dosage Form : Injection

Get a Price/Quote